Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
02/08/2007 | WO2007014456A1 Cancerous disease modifying antibodies |
02/08/2007 | WO2007014455A1 Cancerous disease modifying antibodies |
02/08/2007 | WO2006121852A3 Anti-cd19 antibody therapy for autoimmune disease |
02/08/2007 | WO2006065975A8 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
02/08/2007 | WO2006042109A3 An apparatus for and method of sampling and collecting powders flowing in a gas stream |
02/08/2007 | WO2005052117A3 Improved methods of in vitro protein synthesis |
02/08/2007 | WO2005044987A3 Tocopherol associated protein and uses thereof |
02/08/2007 | WO2004044124A3 Identification of oligoadenylate synthetase-like genes |
02/08/2007 | WO2003068934A3 Chimeric molecules for cleavage in a treated host |
02/08/2007 | US20070033669 Semaphorin gene family |
02/08/2007 | US20070032643 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same |
02/08/2007 | US20070032642 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
02/08/2007 | US20070032419 Fusion polypeptide, which comprise a peptide of 3-30 amino acids, which permits the fusion polypeptide to be bound selectively to tumor vessel endothelial cells, and the tissue factor or a fragment thereof; enables the fusion polypeptide to be bound selectively to tumor vessel endothelial cells |
02/08/2007 | US20070032415 Compositions, splice variants and methods relating to breast specific genes and proteins |
02/08/2007 | US20070031979 Protein biopolymer markers predictive of type II diabetes |
02/08/2007 | US20070031969 Bacteria with reduced genome |
02/08/2007 | US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
02/08/2007 | US20070031945 High mannose proteins and methods of making high mannose proteins |
02/08/2007 | US20070031940 Methods for inducing differentiation of undifferentiated mammalian cells into osteoblasts |
02/08/2007 | US20070031938 Organic anion transporting (oat)-like protein ust3-like1 and uses thereof |
02/08/2007 | US20070031936 Nucleic acid sequences having gene transcription regulatory qualities |
02/08/2007 | US20070031935 Nucleic acid sequences having gene transcription regulatory qualities |
02/08/2007 | US20070031934 Nucleic acid sequences having gene transcription regulatory qualities |
02/08/2007 | US20070031933 Determining whether a DNA sequence comprises a gene transcription modulating quality and/or a gene transcription repressing quality; systematic elucidation and identification of regulatory sequences |
02/08/2007 | US20070031932 Cultures of E1-immortalized cells and processes for culturing the same to increase product yields therefrom |
02/08/2007 | US20070031931 Biosynthetic binding proteins for immuno-targeting |
02/08/2007 | US20070031930 Includes lowering the pH of a whole E coli cell solution to form an acidic solution, disrupting the cells to release the protein into the acidic solution, and separating the cellular debris from the released protein to obtain a protein product enriched in the heterologous target protein |
02/08/2007 | US20070031929 Polypeptides Homologous To VEGF and BMP1 |
02/08/2007 | US20070031928 Glucoamylase variants |
02/08/2007 | US20070031927 Biological system and assay for identifying inhibitors of tubulin glutamylases |
02/08/2007 | US20070031926 Refolded membrane protein in monodisperse form |
02/08/2007 | US20070031925 Small molecular weight TNF receptor multimeric molecule |
02/08/2007 | US20070031924 recombinant polynucleotide that encodes a cell surface polypeptide comprising a biomolecule partition motif that can direct targeting of intracellular polypeptides to and through membranes, including cell surface membranes |
02/08/2007 | US20070031923 Modified viral particles with immunogenic properties and reduced lipid content useful for treating and preventing infectious diseases |
02/08/2007 | US20070031922 Nucleotide sequences coding chimeric immunoglobulin comprising salavage receptor binding epitope for use as reporter in immunodiagnostic and immunotherapeutics |
02/08/2007 | US20070031921 Potent combinations of mrna transport elements |
02/08/2007 | US20070031920 High expression locus vector based on ferritin heavy chain gene locus |
02/08/2007 | US20070031904 Mammalian IAP gene family, primers, probes and detection methods |
02/08/2007 | US20070031903 Mammalian IAP gene family, primers, probes and detection methods |
02/08/2007 | US20070031899 Using serine/threonine kinase Pim-1 polypeptide phosphorylation inhibition after exposure to modulator as indication of antitumor/cancer activity; treating pancreatic cancer |
02/08/2007 | US20070031896 Anti-CCR4 antibodies and methods of use therefor |
02/08/2007 | US20070031894 Novel nerve stem cell marker |
02/08/2007 | US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
02/08/2007 | US20070031882 Methods and compositions for treating AIDS and HIV-related disorders using 1414, 1481,1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784 or 2045 molecules |
02/08/2007 | US20070031879 Novel enterokinase cleavage sequences |
02/08/2007 | US20070031878 Methods and compositions for polypeptide engineering |
02/08/2007 | US20070031860 G-protein coupled receptor and uses therefor |
02/08/2007 | US20070031855 Receptor for a bacillus thuringiensis toxin |
02/08/2007 | US20070031837 Genetic markers for skatole metabolism |
02/08/2007 | US20070031836 Altered Bacillus SecA comprising at least one amino acid change in IRA-1 and/or IRA-2 (intramolecular regulator of ATP hydrolysis) |
02/08/2007 | US20070031506 Interleukin-18 inducer |
02/08/2007 | US20070031478 Modified peptides and their uses |
02/08/2007 | US20070031452 rheumatoid arthritis; nervous system disorders; endogenous retroviral elements (ERV) |
02/08/2007 | US20070031445 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |
02/08/2007 | US20070031444 Compounds targeted to cellular locations |
02/08/2007 | US20070031442 Method and compositions for boosting immune response |
02/08/2007 | US20070031440 Modified transferin-antibody fusion proteins |
02/08/2007 | US20070031439 Novel protein related to melanoma-inhibiting protein and uses thereof |
02/08/2007 | US20070031438 Antibodies as chimeric effector cell receptors against tumor antigens |
02/08/2007 | US20070031436 Bivalent monomeric Fv antibody formed by one single-chain Fv monomer having four variable domains; expression plasmids which code for an Fv antibody; diagnosis; stability; no undesired immune response; side effect reduction; lack constant domains |
02/08/2007 | US20070031435 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
02/08/2007 | US20070031433 Tumor antigen |
02/08/2007 | US20070031432 Tumor antigen |
02/08/2007 | US20070031431 polypeptides consisting of amino acid sequences or peptide fragments and drug carriers, used for inducing and/or activating human leukocyte antigens (HLA-A2)-restricted tumor-specific cytotoxic T lymphocytes; anticancer vaccines |
02/08/2007 | US20070031422 Selection of cells expressing heteromeric polypeptides |
02/08/2007 | US20070031421 Inhibitors targeting osteoclast-associated protein |
02/08/2007 | US20070031414 DR5 antibodies and uses thereof |
02/08/2007 | US20070031410 POP2: NFkB - Inhibiting Polypeptides, Nucleic Acids and Methods of Use |
02/08/2007 | US20070031409 Recombinant DNA-molecule complex for the expression of anti-human-interferon-gamma chimeric antibodies or antibody fragments |
02/08/2007 | US20070031407 Peptide or protein containing a C'-D loop of the CD28 receptor family |
02/08/2007 | US20070031405 Use of A33 antigens and jam-it |
02/08/2007 | US20070031401 Metalloprotease catalytic site for use in identifying modulators for prevention and treatment of respiratory system disorders |
02/08/2007 | US20070031399 Use of proline specific endoproteases to hydrolyse peptides and proteins |
02/08/2007 | US20070031395 Repressor of skeletal muscle differentiation, nucleic acid coding therefor and the use thereof in diagnosis and therapy |
02/08/2007 | US20070031376 In which IL-6R and IL-6 are directly linked without a linker; blood platelet proliferating agent, ex vivo amplifier for hematopoietic stem cells |
02/08/2007 | CA2620937A1 Cancerous disease modifying antibodies |
02/08/2007 | CA2617832A1 Yeast host, transformant and method for producing heterologous proteins |
02/08/2007 | CA2617458A1 Cancerous disease modifying antibodies |
02/08/2007 | CA2617454A1 Cancerous disease modifying antibodies |
02/08/2007 | CA2617447A1 Cancerous disease modifying antibodies |
02/08/2007 | CA2617446A1 Cancerous disease modifying antibodies |
02/08/2007 | CA2617138A1 Mutant timp-3 |
02/07/2007 | EP1749886A2 Polypeptides having kinase activity, their preparation and use |
02/07/2007 | EP1749836A2 Recombinant vascular endothelial cell growth factor D (VEGF-D) |
02/07/2007 | EP1749538A1 Methods of inducing differentiation of regulatory t-cells and proliferating the same with gpi anchor protein agonist and medicinal composition therefor |
02/07/2007 | EP1749102A2 Transgenic animals and uses thereof |
02/07/2007 | EP1749025A2 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer |
02/07/2007 | EP1749022A2 Methods for cyclizing synthetic polymers |
02/07/2007 | EP1497634A4 Protein knobs |
02/07/2007 | EP1272609B1 Single chain antibody against mutant p53 |
02/07/2007 | EP1218491B1 Dna encoding a human subunit 5-ht3-c of the 5-ht3 serotonin receptor |
02/07/2007 | EP1092029B1 Human thrombopoietin mutein |
02/07/2007 | EP0909272B1 Helicobacter pylori adhesin binding group antigen |
02/07/2007 | EP0870022B1 Immunostimulatory composition and method |
02/07/2007 | EP0504363B2 PURIFIED IgG ANTIBODIES |
02/07/2007 | CN1910195A Uses of spatial configuration to modulate protein function |
02/07/2007 | CN1909930A Transglutaminase mediated conjugation of peptides |
02/07/2007 | CN1909922A Novel flavivirus antigens |
02/07/2007 | CN1908183A Enzyme medium hybrid peptide of native protein with endothelin antagonism |
02/07/2007 | CN1908170A Lim mineralization protein splice variants |